1. Deputy Director | NIDA Center for the Clinical Trials Network
Geetha A. Subramaniam, MD, DFAACAP, DFAPA 
Deputy Director | NIDA Center for the Clinical Trials Network 
41st AMERSA Annual National Conference
Thursday, November 2, 2017

2. Products Training Awards Scientific Sessions Exhibits
Mentorship Awards
Symposia/Workshops/Outreach at Professional Meetings
Booth Exhibits (AANP, AAPA)
MI & Adolescent MI CME – Medscape & SiMmersion
Electronic Adolescent Screening Tools: S2BI & BSTAD
Tobacco, Alcohol, Prescription & Other Drug Screening Tool (TAPS)
Open Online Training for Collaborative Care – Harvard CME
Addiction Science & Clinical Practice special series “Substance Use & the HIV Care Continuum”
Podcast – Engaging the Nursing Community in Treatment of Opioid Use Disorder
Whiteboard Video – Buprenorphine

3. Free, online medical education program – each course 8 hours CME/CE
Emphasis on medication for OUD in collaborative care settings where nurses play important role
Course 1: Understanding Addiction
launched April 14, 2017
Course 2: Identification, Counseling, and Treatment of OUD
launched May 15, 2017
Course 3: Collaborative Care Approaches for Management of OUD
launched June 1, 2017.
Each course is certified for 8 hours of CME including approval from ANA, AAPA, AANP and the National Association of Social Workers.

4. Engaging the Nursing Community in Treatment of Opioid Use Disorder
Guest: Colleen T. LaBelle MSN, RN-BC, CARN
Describes how nurses and nurse practitioners can expand patient access to medications for OUD
Highlights benefits of collaborative care approach to facilitate access to buprenorphine in office-based settings

5. Video Tutorial
An educational whiteboard-style video tutorial on the use of Buprenorphine
for OUD
Click on screenshot to start video

6. ….Coming Soon to the NIDA Website
A brief, two-stage screen for substance use and fits into clinical workflows
Dissemination product provides guidance for clinicians
TAPS-1:
Screening
TAPS-2:
Brief Assessment
Validity – Results of a large multisite study* indicated that the TAPS tool identified adults with and without problem use/SUDs in primary care settings  
Easy Access – Uses an electronic format (available as an online tool)
Flexibility – May be either self-administered directly by the patient or administered by a health professional
*McNeely J, Wu L, Subramaniam G, Sharma G, Cathers LA, Svikis D, et al. Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Ann Intern Med. 2016;165: doi: /M

7. …..and NOW on the NIDA Website
Brief Screener for Tobacco, Alcohol, and Drugs (BSTAD)
Screening to Brief Intervention (S2BI)
Both tools begin with a single question each about past-year frequency of use for tobacco, alcohol, and marijuana.
Each screening tool:
May be either self-administered directly by the patient or administered by a health professional
These tools can typically be completed in less than two minutes 
Web-based brief substance use screening tools for use with adolescent patients in pediatric or primary care settings
Implications of the score—along with suggested clinician actions and additional resources—are provided